Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1972 Aug;25(8):680–682. doi: 10.1136/jcp.25.8.680

The detection of fibrinogen/fibrin degradation products by means of a new antibody-coated latex particle

M Bernadette Garvey 1,2, Joan M Black 1,2
PMCID: PMC477476  PMID: 5076802

Abstract

A rapid slide test for the detection of degradation products of fibrinogen/fibrin (FDP) using a new antibody-coated latex particle is described. The latex particle has been specifically coated with antibody to fragments D and E. The latex agglutination test (Thrombo-Wellcotest) has been compared with the tanned red cell haemagglutination inhibition immunoassay (TRCHII) in 143 patients with a variety of clinical conditions. There is a high degree of agreement between the methods with a coefficient of correlation of 0·83. The method provides a rapid, simple screening test for fibrin degradation products.

Full text

PDF
680

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allington M. J. Fibrinogen and fibrin degradation products and the clumping of staphylococci by serum. Br J Haematol. 1967 Jul;13(4):550–567. doi: 10.1111/j.1365-2141.1967.tb00763.x. [DOI] [PubMed] [Google Scholar]
  2. Avrameas S., Ternynck T. The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents. Immunochemistry. 1969 Jan;6(1):53–66. doi: 10.1016/0019-2791(69)90178-5. [DOI] [PubMed] [Google Scholar]
  3. Castelan D. J., Hirsh J., Martin M. Latex-bound antifibrinogen test for plasma fibrinogen assay. J Clin Pathol. 1968 Sep;21(5):638–642. doi: 10.1136/jcp.21.5.638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cohen R. J. Measurement of fibrinogen degradation products. N Engl J Med. 1970 Dec 24;283(26):1465–1466. doi: 10.1056/NEJM197012242832614. [DOI] [PubMed] [Google Scholar]
  5. FERREIRA H. C., MURAT L. G., FERRI R. G. RAPID TEST FOR FIBRINOLYSIS IN VIVO. Transfusion. 1964 Jan-Feb;4:21–25. doi: 10.1111/j.1537-2995.1964.tb02823.x. [DOI] [PubMed] [Google Scholar]
  6. Fisher S., Fletcher A. P., Alkjaersig N., Sherry S. Immunoelectrophoretic characterization of plasma fibrinogen derivatives in patients with pathological plasma proteolysis. J Lab Clin Med. 1967 Dec;70(6):903–922. [PubMed] [Google Scholar]
  7. HIRSH J., FLETCHER A. P., SHERRY S. EFFECT OF FIBRIN AND FIBRINOGEN PROTEOLYSIS PRODUCTS ON CLOT PHYSICAL PROPERTIES. Am J Physiol. 1965 Aug;209:415–424. doi: 10.1152/ajplegacy.1965.209.2.415. [DOI] [PubMed] [Google Scholar]
  8. Hawiger J., Niewiarowski S., Gurewich V., Thomas D. P. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test. J Lab Clin Med. 1970 Jan;75(1):93–108. [PubMed] [Google Scholar]
  9. Lipiński B., Hawiger J., Jeljaszewicz J. Staphylococcal clumping with soluble fibrin mmonomer complexes. J Exp Med. 1967 Nov 1;126(5):979–988. doi: 10.1084/jem.126.5.979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Marder V. J., Matchett M. O., Sherry S. Detection of serum fibrinogen and fibrin degradation products. Comparison of six technics using purified products and application in clinical studies. Am J Med. 1971 Jul;51(1):71–82. doi: 10.1016/0002-9343(71)90325-1. [DOI] [PubMed] [Google Scholar]
  11. Merskey C., Kleiner G. J., Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood. 1966 Jul;28(1):1–18. [PubMed] [Google Scholar]
  12. NILEHN J. E., NILSSON I. M. DEMONSTRATION OF FIBRINOLYTIC SPLIT PRODUCTS IN HUMAN SERUM BY AN IMMUNOLOGICAL METHOD IN SPONTANEOUS AND INDUCED FIBRINOLYTIC STATES. Scand J Haematol. 1964;1:313–330. doi: 10.1111/j.1600-0609.1964.tb00029.x. [DOI] [PubMed] [Google Scholar]
  13. NUSSENZWEIG V., SELIGMANN M., GRABAR P. [The degradation products of human fibrinogen by plasmin. II. Immunological study: existence of native anti-fibrinogen antibodies possessing different specificities]. Ann Inst Pasteur (Paris) 1961 Apr;100:490–508. [PubMed] [Google Scholar]
  14. Stiehm E. R., Trygstad C. W. Split products of fibrin in human renal disease. Am J Med. 1969 May;46(5):774–786. doi: 10.1016/0002-9343(69)90028-x. [DOI] [PubMed] [Google Scholar]
  15. Thomas D. P., Niewiarowski S., Myers A. R., Bloch K. J., Colman R. W. A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases. N Engl J Med. 1970 Sep 24;283(13):663–668. doi: 10.1056/NEJM197009242831301. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES